GO:0070948 regulation of neutrophil mediated cytotoxicity: Immune Killing Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070948 describes any process that modulates the rate, frequency, or extent of neutrophil-mediated killing of a target cell.
• Neutrophils kill targets through phagocytosis, degranulation, reactive oxygen species, and neutrophil extracellular traps (NETs).
• Dysregulated neutrophil cytotoxicity contributes to cancer metastasis, cardiovascular injury, periodontal disease, and tumor immune evasion.
• Key regulatory nodes include Gasdermin D, IL-17/γδ T cell crosstalk, IL-18R1-NF-κB signaling, and ferroptosis pathways.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of this regulatory process.
• EDITGENE provides end-to-end CRISPR cell model and library screening services to study regulation of neutrophil mediated cytotoxicity.
Description
Regulation of neutrophil mediated cytotoxicity (GO:0070948) is a biological process that encompasses any mechanism controlling the rate, frequency, or extent by which neutrophils kill target cells. Neutrophils are the most abundant circulating leukocytes and act as first responders of the innate immune system, deploying a lethal arsenal that includes phagocytosis, degranulation, reactive oxygen species (ROS), and neutrophil extracellular traps (NETs). Because unchecked neutrophil killing can damage healthy tissue, this process is tightly regulated at multiple levels, from cytokine signaling to intracellular checkpoints. Understanding GO:0070948 is therefore central to immunology, cancer biology, and inflammatory disease research. Dysregulation of neutrophil cytotoxicity has been implicated in breast cancer metastasis, where IL-17-producing γδ T cells and neutrophils conspire to promote dissemination, and in tumor immune evasion driven by IL-18-mediated signaling. In cardiovascular disease, Gasdermin D inhibition confers antineutrophil-mediated cardioprotection in acute myocardial infarction. Ferroptotic neutrophils can induce immunosuppression and chemoresistance in breast cancer, and neutrophil-driven inflammation is a hallmark of periodontal diseases. These examples illustrate why precise experimental control over this regulatory process is essential for both mechanistic discovery and therapeutic development.
regulation of neutrophil mediated cytotoxicity At A Glance
| GO ID | GO:0070948 |
|---|---|
| GO term | regulation of neutrophil mediated cytotoxicity |
| Ontology | biological_process |
| Synonym | regulation of neutrophil mediated cell killing |
| Major function | Modulates the rate, frequency, or extent of neutrophil-mediated killing of a target cell |
| Related processes | Neutrophil degranulation, NET formation, ROS production, phagocytosis, cytokine signaling |
| Disease relevance | Cancer metastasis, cardiovascular injury, periodontal disease, tumor immune evasion |
| Experimental focus | CRISPR knockout, point mutation, knock-in, overexpression, and library screening of regulatory genes |
What Is GO:0070948?
According to the Gene Ontology, GO:0070948 (regulation of neutrophil mediated cytotoxicity) is defined as any process that modulates the rate, frequency, or extent of neutrophil mediated killing of a target cell, the directed killing of a target cell by a neutrophil. In simpler terms, it is the set of molecular and cellular controls that determine whether, when, and how strongly a neutrophil kills another cell. The synonym regulation of neutrophil mediated cell killing captures the same concept. This term sits under biological_process and is distinct from the actual killing event itself; it specifically refers to the regulatory inputs that tune neutrophil cytotoxic activity.
Why Is regulation of neutrophil mediated cytotoxicity Important in Cell Biology?
Regulation of neutrophil mediated cytotoxicity is critically important because neutrophils are both essential defenders and potent sources of tissue damage. When this regulation fails, the consequences range from impaired pathogen clearance to chronic inflammation, autoimmunity, and cancer progression. In oncology, neutrophils can be reprogrammed to promote metastasis through IL-17-dependent crosstalk with γδ T cells, and ferroptotic neutrophils can drive immunosuppression and chemoresistance. In cardiovascular disease, Gasdermin D-dependent neutrophil activity contributes to myocardial injury, and its inhibition is cardioprotective. In periodontal disease, inflammatory and immunological mechanisms involving neutrophils underpin tissue destruction. Understanding the regulatory nodes of GO:0070948 therefore offers therapeutic opportunities across a wide spectrum of human diseases.
• Controls the balance between effective pathogen killing and collateral host tissue damage.
• Shapes tumor microenvironment remodeling and metastatic dissemination in breast cancer.
• Modulates chemoresistance and immunosuppression via ferroptotic neutrophils.
• Contributes to acute myocardial infarction injury through Gasdermin D-dependent pathways.
• Drives inflammatory tissue destruction in periodontal diseases.
• Enables tumor immune evasion through IL-18R1-NF-κB signaling.
• Represents a druggable axis for anti-inflammatory and anticancer therapies.
• Provides a mechanistic entry point for CRISPR-based functional genomics.
• Links innate immunity to adaptive immune responses and cytokine networks.
• Offers biomarkers and targets for precision medicine in inflammatory diseases.
What Happens During regulation of neutrophil mediated cytotoxicity?
Neutrophil Activation and Priming
In simple terms: Before a neutrophil can kill, it must first be switched on by signals from the immune system.
Neutrophil cytotoxic activity is initiated by priming signals such as cytokines, chemokines, and pathogen-derived molecules. This priming lowers the threshold for subsequent activation and prepares the cell for rapid killing. Regulation at this stage determines whether the neutrophil remains quiescent or becomes cytotoxic. Key mediators include inflammatory cytokines and damage-associated molecular patterns that tune neutrophil responsiveness.
Target Recognition and Killing Mechanisms
In simple terms: Once activated, the neutrophil identifies a target cell and deploys its killing tools.
Neutrophils kill target cells through multiple mechanisms including phagocytosis, degranulation of antimicrobial peptides and proteases, production of reactive oxygen species (ROS), and release of neutrophil extracellular traps (NETs). Each of these mechanisms is subject to regulation that determines the rate and extent of killing. The choice of killing mechanism can be influenced by the target cell type and the surrounding cytokine milieu.
Gasdermin D and Inflammatory Cell Death
In simple terms: Gasdermin D is a protein that can punch holes in cell membranes, and its activity in neutrophils affects how much damage they cause.
Gasdermin D (GSDMD) is a key regulator of neutrophil-mediated cytotoxicity in the context of acute myocardial infarction. Inhibition of Gasdermin D confers antineutrophil-mediated cardioprotection, demonstrating that GSDMD-dependent pathways modulate neutrophil cytotoxic effects on cardiac tissue. This places GSDMD as a critical node in the regulation of neutrophil mediated cytotoxicity, linking inflammasome signaling to tissue injury.
Cytokine Networks and Immune Crosstalk
In simple terms: Neutrophils do not act alone; they communicate with other immune cells through cytokines.
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis, illustrating how cytokine crosstalk regulates neutrophil cytotoxic and pro-tumor functions. Similarly, IL-18-mediated signaling through the IL-18R1-NF-κB axis promotes tumor immune evasion and progression, with neutrophils as key effectors. These cytokine networks represent upstream regulatory inputs that shape neutrophil activity in the tumor microenvironment.
Metabolic and Ferroptotic Regulation
In simple terms: The metabolic state of a neutrophil, including how it handles iron and lipids, can change how it kills or suppresses immune responses.
Ferroptotic neutrophils induce immunosuppression and chemoresistance in breast cancer, demonstrating that metabolic pathways such as ferroptosis regulate neutrophil-mediated effects on tumors. Mitochondrial metabolism and cancer therapeutic innovation are also linked to neutrophil function in the tumor microenvironment. These findings highlight that regulation of neutrophil mediated cytotoxicity extends beyond classical immune signaling to include metabolic checkpoints.
Key Genes Involved in GO:0070948 regulation of neutrophil mediated cytotoxicity
The following genes and proteins are experimentally implicated in the regulation of neutrophil mediated cytotoxicity and related inflammatory processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GSDMD | Mediates pyroptotic cell death and neutrophil-mediated cardiac injury | Target for cardioprotection in acute myocardial infarction |
| IL17A | Pro-inflammatory cytokine linking γδ T cells and neutrophils | Promotes breast cancer metastasis |
| IL18 | Cytokine that activates NF-κB signaling | Drives tumor immune evasion and progression |
| IL18R1 | Receptor for IL-18 | Activates NF-κB in tumor and immune cells |
| NFKB1 | Transcription factor downstream of IL-18R1 | Mediates inflammatory gene expression in tumor immune evasion |
| ACSL6 | Long-chain acyl-CoA synthetase involved in lipid metabolism | Activates IL-18R1-NF-κB signaling |
| PADI4 | Enzyme required for NET formation | Regulates neutrophil extracellular trap release |
| ELANE | Neutrophil elastase, a serine protease | Mediates degranulation and tissue remodeling |
| MPO | Myeloperoxidase, produces hypochlorous acid | Key ROS-generating enzyme in neutrophils |
| CXCL8 | Chemokine that recruits neutrophils | Regulates neutrophil trafficking and activation |
| TNF | Pro-inflammatory cytokine | Modulates neutrophil priming and cytotoxicity |
| IL1B | Inflammasome-dependent cytokine | Links innate immunity to neutrophil activation |
| CASP1 | Inflammasome caspase that activates GSDMD | Upstream regulator of GSDMD-mediated cytotoxicity |
| NLRP3 | Inflammasome sensor | Activates caspase-1 and GSDMD in neutrophils |
| GPX4 | Glutathione peroxidase 4, protects against ferroptosis | Modulates ferroptotic neutrophil states |
| SLC7A11 | Cystine/glutamate antiporter, regulates ferroptosis | Influences neutrophil survival and ferroptosis |
| NFE2L2 | Transcription factor regulating antioxidant responses | Modulates oxidative stress in neutrophils |
How Is regulation of neutrophil mediated cytotoxicity Regulated?
Regulation of neutrophil mediated cytotoxicity is controlled at multiple levels, including cytokine signaling, inflammasome activation, metabolic checkpoints, and transcriptional programs. IL-17-producing γδ T cells regulate neutrophil pro-metastatic activity through cytokine crosstalk. The IL-18R1-NF-κB axis, activated by ACSL6, promotes tumor immune evasion and involves neutrophil-mediated effects. Gasdermin D, activated downstream of inflammasome signaling, is a critical regulator of neutrophil-mediated cardiac injury. Ferroptosis pathways, including GPX4 and SLC7A11, modulate neutrophil states that induce immunosuppression and chemoresistance. Mitochondrial metabolism also influences neutrophil function in cancer. These layers of regulation ensure that neutrophil killing is context-dependent and tightly controlled.
regulation of neutrophil mediated cytotoxicity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GSDMD | Acute myocardial infarction | Knockout and point mutation models in cardiomyocytes and neutrophils |
| IL17A | Breast cancer metastasis | Knockout and overexpression in γδ T cell and neutrophil co-culture |
| IL18 | Tumor immune evasion | Knockout and knock-in in tumor and immune cells |
| GPX4 | Ferroptosis-mediated chemoresistance | Knockout and overexpression in breast cancer and neutrophil models |
| PADI4 | NET-associated inflammatory disease | Knockout in neutrophil-like cell lines |
Cancer Metastasis and Immune Evasion
Neutrophils promote breast cancer metastasis through IL-17-dependent crosstalk with γδ T cells. Ferroptotic neutrophils induce immunosuppression and chemoresistance in breast cancer. IL-18-mediated signaling through IL-18R1-NF-κB promotes tumor immune evasion and progression. These findings establish regulation of neutrophil mediated cytotoxicity as a central axis in cancer biology.
Cardiovascular Disease
Gasdermin D inhibition confers antineutrophil-mediated cardioprotection in acute myocardial infarction, demonstrating that regulation of neutrophil mediated cytotoxicity directly impacts cardiac injury. This suggests that targeting neutrophil regulatory pathways could reduce myocardial damage.
Periodontal and Inflammatory Diseases
Inflammatory and immunological mechanisms involving neutrophils underpin periodontal tissue destruction. Dysregulated neutrophil cytotoxicity contributes to chronic inflammation and tissue damage in these conditions.
Neutrophil Extracellular Traps in Pathology
Neutrophil extracellular traps (NETs) are implicated in a range of pathologies from autoimmunity to thrombosis, and their regulation is part of GO:0070948. Understanding NET regulation provides therapeutic opportunities in inflammatory and thrombotic diseases.
From regulation of neutrophil mediated cytotoxicity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GSDMD mediate neutrophil cytotoxicity in cardiac injury? | GSDMD knockout and point mutation in neutrophils and cardiomyocytes |
| How does IL-17 signaling regulate neutrophil pro-metastatic activity? | IL17A knockout and overexpression in γδ T cell and neutrophil co-cultures |
| What is the role of IL-18R1-NF-κB in tumor immune evasion? | IL18R1 knockout and NFKB1 knock-in in tumor cells |
| How does ferroptosis modulate neutrophil immunosuppression? | GPX4 knockout and SLC7A11 overexpression in neutrophil models |
| What is the impact of NET formation on inflammation? | PADI4 knockout in neutrophil-like cells |
| Can mitochondrial metabolism be targeted to alter neutrophil function? | NFE2L2 knockout and overexpression in cancer and immune cells |
How to Study the regulation of neutrophil mediated cytotoxicity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality for neutrophil cytotoxicity | Discovery of regulatory genes |
| In vitro cytotoxicity assay | Target cell killing by neutrophils | Functional validation of candidate genes |
| Immunofluorescence for NETs | NET formation and release | Quantification of neutrophil extracellular traps |
| Phospho-flow cytometry | Signaling pathway activation | Analysis of IL-18R1-NF-κB and IL-17 signaling |
| Ferroptosis assays | Lipid peroxidation and cell death | Study of ferroptotic neutrophil states |
| Inflammasome activation assays | Caspase-1 and GSDMD cleavage | Investigation of GSDMD-mediated cytotoxicity |
| Cytokine multiplex assays | Secreted cytokine profiles | Characterization of neutrophil crosstalk |
| Mitochondrial function assays | Metabolic activity | Assessment of metabolic regulation |
CRISPR Functional Genomics
CRISPR knockout and activation screens enable systematic discovery of genes that regulate neutrophil mediated cytotoxicity. Libraries targeting kinases, phosphatases, and immune regulators can identify novel modulators of neutrophil killing.
Cytotoxicity Assays
In vitro cytotoxicity assays measure the ability of neutrophils to kill target cells, such as tumor cells or infected cells. These assays can be coupled with genetic perturbations to dissect regulatory pathways.
NET Visualization and Quantification
Imaging-based methods, including immunofluorescence and live-cell microscopy, quantify NET formation and neutrophil extracellular trap release. These methods are essential for studying the regulatory steps of GO:0070948.
Cytokine and Signaling Profiling
Multiplex cytokine assays and phospho-flow cytometry measure signaling pathways such as IL-18R1-NF-κB and IL-17 that regulate neutrophil activity. These readouts link upstream signals to downstream cytotoxic functions.
How CRISPR Can Be Used to Study GO:0070948 regulation of neutrophil mediated cytotoxicity
Knockout
CRISPR knockout of genes such as GSDMD, IL17A, IL18R1, and GPX4 enables loss-of-function studies to determine their causal role in regulation of neutrophil mediated cytotoxicity. Knockout models are essential for validating targets identified in screens.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to abrogate specific catalytic or binding activities. For example, point mutations in GSDMD can dissect its pore-forming function from other activities.
Knock-in
Knock-in of tagged or reporter alleles allows real-time tracking of protein localization and expression during neutrophil activation. This is particularly useful for studying dynamic processes such as NET formation.
Overexpression
Overexpression of regulatory genes such as IL18, ACSL6, or GPX4 can drive gain-of-function phenotypes to test sufficiency in promoting or suppressing neutrophil cytotoxicity.
How EDITGENE Supports regulation of neutrophil mediated cytotoxicity Research
Researchers studying regulation of neutrophil mediated cytotoxicity-related genes often need to determine whether a candidate gene is causally involved in modulating neutrophil killing, or whether it is merely a bystander. EDITGENE provides the CRISPR tools and cell models required to establish causality with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of neutrophil mediated cytotoxicity research.
Frequently Asked Questions About regulation of neutrophil mediated cytotoxicity
What is regulation of neutrophil mediated cytotoxicity (GO:0070948)?
It is a biological process that modulates the rate, frequency, or extent of neutrophil-mediated killing of a target cell.
What genes are involved in regulation of neutrophil mediated cytotoxicity?
Key genes include GSDMD, IL17A, IL18, IL18R1, NFKB1, ACSL6, GPX4, SLC7A11, PADI4, ELANE, MPO, and CXCL8.
How do neutrophils kill target cells?
Neutrophils kill through phagocytosis, degranulation, reactive oxygen species, and neutrophil extracellular traps.
What is the role of Gasdermin D in neutrophil cytotoxicity?
Gasdermin D mediates neutrophil-dependent cardiac injury, and its inhibition is cardioprotective in acute myocardial infarction.
How is neutrophil cytotoxicity regulated in cancer?
IL-17-producing γδ T cells and neutrophils promote metastasis, while IL-18R1-NF-κB signaling drives tumor immune evasion.
What are neutrophil extracellular traps (NETs)?
NETs are web-like structures released by neutrophils that trap and kill pathogens, and their formation is regulated as part of GO:0070948.
Can CRISPR be used to study regulation of neutrophil mediated cytotoxicity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of regulatory genes.
What diseases are linked to dysregulated neutrophil cytotoxicity?
Cancer metastasis, cardiovascular injury, periodontal disease, and inflammatory disorders are linked to dysregulated neutrophil activity.
What experimental models are used to study GO:0070948?
In vitro cytotoxicity assays, NET imaging, cytokine profiling, and CRISPR screens are commonly used.
How does ferroptosis regulate neutrophil function?
Ferroptotic neutrophils induce immunosuppression and chemoresistance in breast cancer, involving GPX4 and SLC7A11.
Conclusion
Regulation of neutrophil mediated cytotoxicity (GO:0070948) is a central biological process that controls how neutrophils kill target cells, with profound implications for cancer, cardiovascular disease, and inflammatory disorders. Understanding its regulatory nodes, from Gasdermin D to cytokine networks and metabolic checkpoints, offers therapeutic opportunities and requires robust experimental models. CRISPR-based approaches provide the precision needed to dissect these pathways and identify new targets.
References
- 1. Hidalgo A et al.. 2022. Neutrophil extracellular traps: from physiology to pathology.. Cardiovasc Res 118(13):2737-2753 PMID: 34648022
- 2. Du H et al.. 2025. Mitochondrial metabolism and cancer therapeutic innovation.. Signal Transduct Target Ther 10(1):245 PMID: 40754534
- 3. Coffelt SB et al.. 2015. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis.. Nature 522(7556):345-348 PMID: 25822788
- 4. Baima G et al.. 2025. Inflammatory and Immunological Basis of Periodontal Diseases.. J Periodontal Res PMID: 41065279
- 5. Zeng W et al.. 2025. Ferroptotic Neutrophils Induce Immunosuppression and Chemoresistance in Breast Cancer.. Cancer Res 85(3):477-496 PMID: 39531510
- 6. Jiang K et al.. 2022. Gasdermin D inhibition confers antineutrophil-mediated cardioprotection in acute myocardial infarction.. J Clin Invest 132(1) PMID: 34752417
- 7. Di Y et al.. 2024. ACSL6-activated IL-18R1-NF-κB promotes IL-18-mediated tumor immune evasion and tumor progression.. Sci Adv 10(38):eadp0719 PMID: 39292786
